病例系列：溃疡性结肠炎、多发性硬化症与干扰素β-1a - Suppr

Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a.

作者信息

Rodrigues S, Magro F, Soares J, Nunes A C R, Lopes S, Marques M, Rio E, Macedo G

出版信息

Inflamm Bowel Dis. 2010 Dec;16(12):2001-3. doi: 10.1002/ibd.21242.

DOI:10.1002/ibd.21242

PMID:20186933

Abstract

摘要

相似文献

Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a.

Inflamm Bowel Dis. 2010 Dec;16(12):2001-3. doi: 10.1002/ibd.21242.

Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.

World J Gastroenterol. 2007 Jul 14;13(26):3638-40. doi: 10.3748/wjg.v13.i26.3638.

Rapid onset of ulcerative colitis after treatment with interferon β1a in a patient with multiple sclerosis.

J Crohns Colitis. 2011 Feb;5(1):75-6. doi: 10.1016/j.crohns.2010.10.007. Epub 2010 Nov 26.

Disease modifying treatment in multiple sclerosis.

J Neurol Neurosurg Psychiatry. 2001 Dec;71 Suppl 2(Suppl 2):ii20-1. doi: 10.1136/jnnp.71.suppl_2.ii20.

Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production.

Gut. 2011 Apr;60(4):449-55. doi: 10.1136/gut.2010.226860. Epub 2010 Oct 22.

[Possibilities and limits of immunotherapy in multiple sclerosis. Inflammatory and degenerative aspects of the disease require a new pathogenetic concept].

Nervenarzt. 2003 Jun;74(6):537-8; discussion 539. doi: 10.1007/s00115-003-1523-4. Epub 2003 May 14.

Lessons from type I interferons in ulcerative colitis.

Gut. 2011 Apr;60(4):430-1. doi: 10.1136/gut.2010.229138. Epub 2011 Jan 25.

Multiple sclerosis--Part 2. Treatment strategies.

J Am Osteopath Assoc. 1999 Dec;99(12):611-9. doi: 10.7556/jaoa.1999.99.12.611.

[Disease-modifying treatments in multiple sclerosis].

Rev Prat. 1999 Nov 1;49(17):1882-9.

[Side-effects of the treatment with disease modifying drugs in patients with multiple sclerosis: an analysis of register data in the Yaroslavl region].

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(8):27-33.

引用本文的文献

Inflammatory bowel disease is associated with an increase in the incidence of multiple sclerosis: a retrospective cohort study of 24,934 patients.

Eur J Med Res. 2024 Mar 20;29(1):186. doi: 10.1186/s40001-024-01776-w.

Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports.

Curr J Neurol. 2023 Apr 4;22(2):115-136. doi: 10.18502/cjn.v22i2.13340.

Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with intestinal bowel disease in multiple sclerosis: a review.

Front Pharmacol. 2023 May 30;14:1186016. doi: 10.3389/fphar.2023.1186016. eCollection 2023.

Multiple sclerosis and inflammatory bowel disease: A systematic review and meta-analysis.

Ann Clin Transl Neurol. 2022 Feb;9(2):132-140. doi: 10.1002/acn3.51495. Epub 2022 Jan 29.

Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases.

Nat Commun. 2021 Sep 24;12(1):5641. doi: 10.1038/s41467-021-25768-0.

Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders.

Ther Adv Neurol Disord. 2021 Aug 23;14:17562864211035542. doi: 10.1177/17562864211035542. eCollection 2021.

Stimulator of interferon genes (STING) activation exacerbates experimental colitis in mice.

Sci Rep. 2019 Oct 3;9(1):14281. doi: 10.1038/s41598-019-50656-5.

Induction or aggravation of other immune-mediated disorders by disease-modifying therapy in treatment of multiple sclerosis.

Iran J Neurol. 2018 Jul 6;17(3):129-136.

The Protective Role of Type I Interferons in the Gastrointestinal Tract.

Front Immunol. 2017 Apr 6;8:410. doi: 10.3389/fimmu.2017.00410. eCollection 2017.

Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitis.

PLoS One. 2011 Feb 18;6(2):e16967. doi: 10.1371/journal.pone.0016967.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献